- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 1.77K sh |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $259K |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $333K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.31M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $3.37M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.34M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $4.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $12.75M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $12.8M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $29.38M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $29.53M |
| Operating Income | Q1 2025 · Sep 30, 2024 | $481K |
| Operating Income | Q1 2025 · Jun 30, 2024 | $832K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$13K |
| Operating Income restated | Q1 2025 · Dec 31, 2023 | −$60K |
| Operating Income | Q1 2025 · Sep 30, 2023 | $537K |
| Operating Income | Q1 2025 · Jun 30, 2023 | $653K |
| Operating Income | Q1 2025 · Mar 31, 2023 | −$33K |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 1.77K sh |
| Capex restated | Q1 2025 · Dec 31, 2023 | $61K |
| Operating Cash Flow restated | Q1 2025 · Dec 31, 2023 | $114K |
| Short Term Investments | Q1 2025 · Dec 31, 2023 | $1.1M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $24.05M |
| Stockholders Equity restated | Q1 2025 · Sep 30, 2023 | $24.02M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $9.00 |
| Eps Basic restated | Q1 2025 · Dec 31, 2023 | $9.00 |
| Net Income restated | Q1 2025 · Dec 31, 2023 | $16K |
| Cost Of Revenue restated | Q1 2025 · Dec 31, 2023 | $87K |
| Revenue restated | Q1 2025 · Dec 31, 2023 | $2.09M |
| Revenue | Q1 2025 · Sep 30, 2023 | $2.88M |
| Revenue | Q1 2025 · Jun 30, 2023 | $2.7M |
| Revenue | Q1 2025 · Mar 31, 2023 | $2.01M |